Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

One can hope the play for Interim Data is also a play for a licensing and distribution deal for NP-120. With an Emergency Use Authorization approval will come expenses. We need another player (hopefully mega player) in the game to thwart off further dilution. That would be the best of both worlds.

CJM, CEO

With the quickly increasing global threat from COVID-19, we believe we have an obligation to find out now how our COVID-19 trial is trending,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals. “If Ifenprodil has been performing well in the study, this early look at the data may allow us to accelerate our COVID-19 program accordingly.

The early look is definitely a card worth playing at this point. The POTUS election is over (believe it or not) and my guess is the stranglehold on FDA decisions have fallen to the wayside. Worthy treatments will likely get a fair shake without the injection of pure, raw, impeding politics at play.

Algernon Pharmaceuticals may end Calendar Year 2020 with a BANG heard around the world.

Captain Obvious


GL2ALL@AGNPF

Just 1 opinion,

/////AMG

PostScript

BLA $ T FR OM D A PA $ T